Search Ontology:
ChEBI

alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-2-acetamido-2,3-dideoxy-beta-D-xylo-hexopyranose

Term ID
CHEBI:149250
Synonyms
  • 6-deoxy-alpha-L-galacto-hexopyranosyl-(1->2)-beta-D-galacto-hexopyranosyl-(1->4)-2-acetamido-2,3-dideoxy-beta-D-xylo-hexopyranose
  • alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2,3-dideoxy-beta-D-xylo-hexopyranose
  • Fuc(a1-2)Gal(b1-4)3-deoxy-b-D-xylHexNAc
  • N-[(2R,3R,5R,6R)-5-[(2R,3R,4S,5R,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2-hydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
Definition
An amino trisaccharide consisting of α-L-fucopyranose, β-D-galactopyranose and 2-acetamideo-2,3-dideoxy-β-D-xylo-hexopyranose residues joined in sequence by (1→2) and (1→4) glycosidic bonds.
References
  • glygen:G32227EH
  • glytoucan:G32227EH
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-2-acetamido-2,3-dideoxy-beta-D-xylo-hexopyranose
Phenotype where environments contain alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-2-acetamido-2,3-dideoxy-beta-D-xylo-hexopyranose
Phenotype modified by environments containing alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-2-acetamido-2,3-dideoxy-beta-D-xylo-hexopyranose
Phenotype affecting alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-2-acetamido-2,3-dideoxy-beta-D-xylo-hexopyranose
Human Disease Model